A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the antiviral activity, safety, and pharmacokinetics of saquinavir hard gel
capsule (HGC) formulation, to 1 of 3 doses of saquinavir soft gel capsule (SGC) formulation
administered orally every 8 hours for 4 weeks.